Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Parkinson's disease: etiopathogenesis and treatment
J Jankovic, EK Tan - Journal of Neurology, Neurosurgery & Psychiatry, 2020 - jnnp.bmj.com
The concept of 'idiopathic'Parkinson's disease (PD) as a single entity has been challenged
with the identification of several clinical subtypes, pathogenic genes and putative causative …
with the identification of several clinical subtypes, pathogenic genes and putative causative …
Alzheimer's and Parkinson's disease therapies in the clinic
P Chopade, N Chopade, Z Zhao… - Bioengineering & …, 2023 - Wiley Online Library
Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent
neurodegenerative diseases, affecting millions and costing billions each year in the United …
neurodegenerative diseases, affecting millions and costing billions each year in the United …
[PDF][PDF] Parkinson disease epidemiology, pathology, genetics, and pathophysiology
SYNOPSIS (1 paragraph): Parkinson's disease (PD) is a complex age-related
neurodegenerative disease associated with dopamine deficiency and both motor and …
neurodegenerative disease associated with dopamine deficiency and both motor and …
[HTML][HTML] Hypoxia and brain aging: Neurodegeneration or neuroprotection?
The absolute reliance of the mammalian brain on oxygen to generate ATP renders it acutely
vulnerable to hypoxia, whether at high altitude or in clinical settings of anemia or pulmonary …
vulnerable to hypoxia, whether at high altitude or in clinical settings of anemia or pulmonary …
The ageing brain: molecular and cellular basis of neurodegeneration
Ageing is an inevitable event in the lifecycle of all organisms, characterized by progressive
physiological deterioration and increased vulnerability to death. Ageing has also been …
physiological deterioration and increased vulnerability to death. Ageing has also been …
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's …
We developed an endophenotype disease module-based methodology for Alzheimer's
disease (AD) drug repurposing and identified sildenafil as a potential disease risk modifier …
disease (AD) drug repurposing and identified sildenafil as a potential disease risk modifier …
α-synuclein in the pathophysiology of Alzheimer's disease
D Twohig, HM Nielsen - Molecular neurodegeneration, 2019 - Springer
The Alzheimer's disease (AD) afflicted brain is neuropathologically defined by extracellular
amyloid-β (Aβ) plaques and intraneuronal neurofibrillary tangles composed of …
amyloid-β (Aβ) plaques and intraneuronal neurofibrillary tangles composed of …
CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson's disease
There is no consensus on the exact role of the adaptive immune system in Parkinson's
disease pathogenesis, although there is increasing evidence that it is somehow involved …
disease pathogenesis, although there is increasing evidence that it is somehow involved …
Potential role of mitochondria-associated endoplasmic reticulum membrane proteins in diseases
H Mao, W Chen, L Chen, L Li - Biochemical pharmacology, 2022 - Elsevier
Mitochondria-associated endoplasmic reticulum membranes (MAMs) are dynamic
membrane coupling regions formed by the coupling of the mitochondrial outer membrane …
membrane coupling regions formed by the coupling of the mitochondrial outer membrane …
[HTML][HTML] Overlap** neuroimmune mechanisms and therapeutic targets in neurodegenerative disorders
Many potential immune therapeutic targets are similarly affected in adult-onset
neurodegenerative diseases, such as Alzheimer's (AD) disease, Parkinson's disease (PD) …
neurodegenerative diseases, such as Alzheimer's (AD) disease, Parkinson's disease (PD) …